Change in Alanine Aminotransferase From Baseline;Change in Albumin Form Baseline;Change in Alkaline Phosphatase From Baseline;Change in Aspartate Aminotransferase From Baseline;Change in Basophils From Baseline;Change in Bilirubin From Baseline;Change in Creatinine Form Baseline;Change in Direct Bilirubin Form Baseline;Change in Eosinophils From Baseline;Change in Erythrocytes From Baseline;Change in Hematocrit From Baseline;Change in Hemoglobin From Baseline;Change in Lactate Dehydrogenase From Baseline;Change in Leucocytes From Baseline;Change in Lymphocytes From Baseline;Change in Monocytes From Baseline;Change in Neutrophils From Baseline;Change in Platelets From Baseline;Change in Potassium From Baseline;Change in Sodium From Baseline;Change in Urea Nitrogen From Baseline;Occurrence of Serious AE 24 Weeks Following the Vaccination;Occurrence of Solicited Local AE Signs and Symptoms 7 Days Following the Vaccination;Occurrence of Solicited Systemic AE Signs and Symptoms 7 Days Following the Vaccination;Occurrence of Unsolicited AE 28 Days Following the Vaccination

Change in Alanine Aminotransferase From Baseline;Change in Albumin Form Baseline;Change in Alkaline Phosphatase From Baseline;Change in Aspartate Aminotransferase From Baseline;Change in Basophils From Baseline;Change in Bilirubin From Baseline;Change in Creatinine Form Baseline;Change in Direct Bilirubin Form Baseline;Change in Eosinophils From Baseline;Change in Erythrocytes From Baseline;Change in Hematocrit From Baseline;Change in Hemoglobin From Baseline;Change in Lactate Dehydrogenase From Baseline;Change in Leucocytes From Baseline;Change in Lymphocytes From Baseline;Change in Monocytes From Baseline;Change in Neutrophils From Baseline;Change in Platelets From Baseline;Change in Potassium From Baseline;Change in Sodium From Baseline;Change in Urea Nitrogen From Baseline;Occurrence of Serious AE 24 Weeks Following the Vaccination;Occurrence of Solicited Local AE Signs and Symptoms 7 Days Following the Vaccination;Occurrence of Solicited Systemic AE Signs and Symptoms 7 Days Following the Vaccination;Occurrence of Unsolicited AE 28 Days Following the Vaccination

Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of solicited systemic AE signs and symptoms;Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of serious AE;Assess the safety of GRAd-COV2 by laboratory measures: full blood count; blood Biochemistry (Sodium, Potassium, Albumin, Liver Function Tests; Renal function, lactate dehydrogenases (LDH), alkaline phosphatases (ALP)).;Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of unsolicited AE;Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of solicited local AE signs and symptoms

Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of solicited systemic AE signs and symptoms;Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of serious AE;Assess the safety of GRAd-COV2 by laboratory measures: full blood count; blood Biochemistry (Sodium, Potassium, Albumin, Liver Function Tests; Renal function, lactate dehydrogenases (LDH), alkaline phosphatases (ALP)).;Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of unsolicited AE;Assess the safety, tolerability and reactogenicity of GRAd-COV2: Occurrence of solicited local AE signs and symptoms